SpaceX, de Elon Musk, faz maior IPO da história e é avaliada em US$ 1,77 trilhão Ivar AI

BusinessLine

SpaceX IPO pushes Elon Musk’s net worth past $1 trillion

The Times of India

US stocks: SpaceX to make historic listing on Nasdaq on Friday that could make Elon Musk a trillionaire

36kr.com

SpaceX获得三大债券评级机构的投资级评级

New York Post

Meta and Mike Rowe launch $115 trade-training program that guarantees jobs to future welders, plumbers, electricians

BBC News

SpaceX é avaliada em mais de R$ 9 trilhões antes da abertura de capital que pode fazer de Elon Musk o primeiro trilionário da história

BBC News

EUA lançam novos ataques contra o Irã após Trump ameaçar 'atingir o país com força' diante da falta de acordo

The Times of India

Gulf countries act as propellants for SpaceX IPO as billions flow in

Yahoo Entertainment

美國會遏阻伊朗無人機技術中東衝突升級油價飆漲

The Times of India

US stocks: Oppenheimer launches Wall Street's first coverage of SpaceX with bullish outlook

Crypto Briefing

Iran shuts down Strait of Hormuz after US military strikes

Foreign Policy

Trump Says More Strikes on Iran Are Coming

Israel contra Irán: el nuevo equilibrio geopolítico que cambia las reglas del juego

Forbes

Global AI Buildout Proves Wealth Lode For Its Picks-And-Shovels Billionaires In Taiwan

Diariobitcoin.com

EE. UU. ataca Irán tras caída de helicóptero estadounidense frente a Omán

Www.df.cl

Grenergy inaugura en Antofagasta la planta de baterías "más grande de América" y Kast apunta a "ojalá ser el país que más inversión atraiga"

Abril.com.br

SpaceX estreia na Bolsa com IPO recorde de US$ 75 bilhões

Hipertextual

SpaceX sale a la bolsa por 1,77 billones de dólares: la mayor oferta pública de la historia

Crypto Briefing

US Army helicopter shot down by Iran near Strait of Hormuz, Trump confirms

N-tv.de

Nach Hubschrauber-Abschuss: "Selbstverteidigung": US-Militär fliegt neue Angriffe gegen den Iran

Forbes

Investor Demand For SpaceX IPO Tops $250 Billion, Report Says

BusinessLine

US inflation climbs to 4.2% and hits 3-year high amid rising fuel costs

$Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire$

GlobeNewswire

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire